PRESS RELEASE published on 02/29/2024 at 14:30, 8 months 20 days ago Fremedica Partners with UBC Men's Hockey Team to Launch an Innovative Sports Performance Enhancement & Recovery Program FREmedica partners with UBC Men's Hockey Team to launch a revolutionary Sports Performance Enhancement & Recovery Program, aiming to improve athletic performance, facilitate recovery, and support academic focus Frequency Exchange Corp. FREmedica Technologies Inc. UBC Men's Hockey Team Sports Performance Enhancement & Recovery Program Academic Focus
BRIEF published on 02/29/2024 at 14:30, 8 months 20 days ago Partnership between FREmedica and the UBC men's hockey team for an innovative program Wearable Technology FREmedica Technologies Sports Performance Athletic Recovery Education And Sport
PRESS RELEASE published on 11/20/2023 at 14:30, 1 year ago Allison Butenschon and Alexandra Moresco Join Fremedica Advisory Board
PRESS RELEASE published on 11/17/2023 at 14:30, 1 year ago Fremedica License Expansion Launches New Revenue Opportunities
PRESS RELEASE published on 05/10/2023 at 14:30, 1 year 6 months ago Fremedica Signs $500,000 White Label Deal With a Group From Israel
PRESS RELEASE published on 03/30/2023 at 14:00, 1 year 7 months ago "NIKKI CONNECT" App Is Now Approved
PRESS RELEASE published on 01/19/2023 at 14:30, 1 year 10 months ago Jeff Barnes Extends Relationship With FREmedica Technologies as Chief Marketing Officer
Published on 11/21/2024 at 13:30, 32 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 32 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 2 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 2 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 2 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 27 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 47 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 4 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 42 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 17 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 17 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
